Contrave, Extended-Release - Naltrexone hydrochloride and bupropion hydrochloride, Extended-Release 90 mg / 1; 8 mg / 1 Tablet 7 Tablet, Extended Release
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 51267-0890-07 |
|---|---|
| Product NDC | 51267-0890 |
| Generic Drug Name | naltrexone hydrochloride and bupropion hydrochloride, Extended-Release |
| Brand Name | Contrave, Extended-Release |
| Manufacturer | Nalpropion Pharmaceuticals LLC |
| Strength | 90 mg / 1; 8 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 7 Tablet, Extended Release |
| Package Description | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07) |
| Active Ingredients | Bupropion Hydrochloride; Naltrexone Hydrochloride |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
naltrexone hydrochloride and bupropion hydrochloride, Extended-Release 90 mg / 1; 8 mg / 1 Tablet is tracked under NDC 51267-0890-07 and rolls up into product family 51267-0890. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.
- Package configuration: 7 Tablet, Extended Release.
- Manufacturer: Nalpropion Pharmaceuticals LLC.
- Dosage form: Tablet.
- Family size: 2 indexed presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Contrave, Extended-Release - Naltrexone hydrochloride and bupropion hydrochloride, Extended-Release 90 mg / 1; 8 mg / 1 Tablet 7 Tablet, Extended Release, NDC 51267-0890-07, is a Nalpropion Pharmaceuticals LLC 90 mg / 1; 8 mg / 1 tablet presentation packaged as 7 Tablet, Extended Release.
NDC search formats
- Canonical NDC 11: 51267-0890-07
- Digits-only NDC 11: 51267089007
- Possible 10-digit display formats: 51267-890-07 (5126789007), 51267-0890-7 (5126708907)
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Contrave, Extended-Release
- Exact NDC 11: 51267-0890-07
- Product family NDC: 51267-0890
- Other package sizes in this family: 120 Tablet, Extended Release
- Compare related presentations: Contrave, Extended-Release - Naltrexone hydrochloride and bupropion hydrochloride, Extended-Release 90 mg / 1; 8 mg / 1 Tablet 120 Tablet, Extended Release
- VA classification code: CN900
- VA classification code description: CNS MEDICATIONS,OTHER
- CMOP ID: B0782
- VUID: 4035110